Undisclosed Venture Capital
Biotech Investor · 6 portfolio companies
Portfolio
6
Focus Areas
6
Top Stage
preclinical
Portfolio Companies
| Company | Valuation |
|---|---|
| VelaVigo | — |
| Link Cell Therapies | — |
| NeuroDx AI | — |
| Novatim Immune Therapeutics | — |
| DJS Antibodies | — |
| NexCure | — |